Hey there, Over the past week, you have received several emails about MarketBeat All Access, but you didn’t sign up for the 30-day free trial.
I'll be honest; I was surprised to see you haven't accepted this offer. I am a little confused only because we had many people start the trial; I thought you'd be one of them. With this trial, customers have discovered and appreciated the unique advantage this service provides with its best-in-class portfolio monitoring tools and full access to MarketRank stock ratings. So why didn't you accept this offer?
I took some time to think about the possible hesitation from people like you, and suddenly, it all made sense.
Yes, it is completely free to get the 30 day trial subscription, and I don't think anyone is complaining about that. However, I would assume the fear of getting credit card charges immediately after the trial ends stops so many customers in their tracks.
We've all had at least one free trial experience with an unscrupulous marketer behind it who has made it impossible to cancel in time. And then fight us tooth and nail on the refund. No one wants to deal with that.
We don't either and that is not the way we do business!
Then again, how would you know we don't take that approach? We haven't met in person. We’re just a South Dakota-based media and research company that sends timely investment news and ideas to your inbox. So, let's address this head on to give you the reassurance you need to start your 30-day trial: - Renewal Reminder. 7 days before the end of the trial, we will send you a reminder email to cancel. Almost no one in the industry does this. We only want you to pay for a subscription if you actually find value in it.
- 30-Day Satisfaction Guarantee. You may cancel up to 30 days after the trial converts to a paid membership and get a full refund if you are unsatisfied for any reason. No questions asked. No commitment needed.
There is no risk in moving ahead with a 30-day trial of MarketBeat All Access.
Our team has spent years building best-in-class research tools and hiring the best editors to help you identify the best stock ideas for your portfolio. With your free subscription, you’ll get full access to our MarketRank ratings, top stock lists, portfolio monitoring tools, advanced research tools, and premium newsletters.
Our tools, reports, and newsletters provide you with the market commentary and financial data you need to stay on top of the market action. We’ll show you which stocks Wall Street’s top analysts are fawning over and whether we think they’re right. We’ll send you short-term trading alerts when we think there’s an obvious 5-day or 10-day trade to ride a wave of market news. Best of all, our editors go the extra mile to explain the all-important "WHY" behind each trade. As in, why is the stock attractive and what is the upside potential?
If you want to discover the successful methods that my team of experts and I use to outperform the market, get started with a 30-day trial to MarketBeat All Access. Over the next 30 days, you will get ongoing commentary and updated trades to find more ways to carve profits out of this challenging market environment.
After that, the choice is yours. Cancel if it doesn't suit your needs. Or stay on board to enjoy years of investment success.
I have removed the risk so that you can enjoy the reward. Click below to get started!
Get your 30-day trial of MarketBeat All Access here Talk soon,
William Bushee
Vice President, MarketBeat.com
Just For You Rocket Lab: A Parabolic Run Meets a Healthy PullbackWritten by Ryan Hasson 
Key Points - Rocket Lab shares recently surged to a record high amid bullish sentiment and momentum-driven capital rotation, fueled by optimism around its Neutron rocket and Wall Street upgrades.
- After an overbought RSI and a parabolic run, RKLB pulled back double-digits in percent terms from its recent high.
- The company’s long-term upside hinges on Neutron’s success and its evolution into a full-stack space infrastructure firm.
Rocket Lab USA (NASDAQ: RKLB), a leading player in the space infrastructure sector, has been on a tear in 2025. Shares surged to a fresh all-time high of $53.44 last week, with the stock approaching a near-parabolic trajectory on the daily chart. The explosive rally was driven by a wave of capital rotating into high-growth, high-momentum names, especially those with a clear path to profitability and future catalysts. For Rocket Lab, optimism surrounding its upcoming Neutron rocket and growing visibility on Wall Street helped fuel its vertical move. The stock had already garnered attention from major firms like Cantor Fitzgerald and Citi, which recently raised their price targets. Retail enthusiasm only added to the momentum as RKLB entered the price discovery phase. The Pullback: Time to Worry? With any meteoric rise, the question becomes: when does momentum shift into exhaustion? Shares of Rocket Lab have pulled back more than 10% from their all-time high, currently consolidating around the $45 level. Still, the stock remains up an impressive 84% year to date and nearly 800% over the past 12 months, a staggering return by any measure. After breaking through long-term resistance in late June and accelerating through $35, RKLB staged a swift run that pushed the Relative Strength Index (RSI) into the mid-80s. Such an extreme reading rarely goes unnoticed. It signaled an overheated rally and the likelihood of a near-term breather, which is now underway. However, from a technical perspective, there’s little evidence to suggest the broader uptrend is in danger. The stock appears to be digesting its gains constructively, forming a potential higher low near potential short-term support. With the RSI back to around 70, overbought pressure has eased. If RKLB can stabilize here and confirm this support level, the trend may very well resume, fueled by strong fundamentals and upcoming catalysts. Neutron Rocket: A Game Changer on the Horizon Much of Rocket Lab’s long-term bull case revolves around Neutron, its medium-lift, reusable rocket designed to compete with SpaceX’s Falcon 9. The company has already made substantial progress toward its first launch, with Neutron development facilities coming online and key hardware undergoing testing. Neutron will enable Rocket Lab to target a broader commercial and government customer base with larger payloads, dramatically expanding its total addressable market. The company has also made it clear that Neutron isn’t just about launch. It's a cornerstone of a vertically integrated space strategy that includes satellite manufacturing, spacecraft components, and end-to-end mission services. Investors are increasingly viewing Rocket Lab as more than just a launch provider; it’s a full-stack space infrastructure firm. Past Catalysts Keep the Narrative Intact The recent run wasn’t built solely on hype. Rocket Lab’s 2024 performance laid the foundation for its 2025 surge. The company scored key wins, including contracts with NASA, the U.S. Space Force, and commercial satellite providers. Its Electron rocket remains one of the most reliable small-lift vehicles in the world. With dozens of successful missions under its belt, Rocket Lab has earned its reputation for execution. Analysts Are Taking Notice Wall Street hasn’t been shy about its enthusiasm. Analysts continue to raise their targets, citing the growing pipeline, Neutron’s potential, and the strategic shift into space infrastructure services. Cantor Fitzgerald’s $35 price target already proved conservative. RKLB smashed through it weeks ago. And other firms are now revisiting their models in light of the stock’s breakout and the company’s updated roadmap. Citigroup recently boosted its price target from $33 to $50. A Parabolic Run Meets a Healthy Pullback The recent dip in Rocket Lab’s share price is more a function of healthy technical digestion than a change in narrative. For investors with a longer-term outlook, this pullback may present an opportunity, rather than a warning. The rocket ride may be far from over as long as RKLB continues to hold its trend, build support, and execute on the Neutron vision.
| 
0 Response to "I'm confused..."
Post a Comment